BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 4133464)

  • 1. Letter: 5-hydroxyindoleacetic acid in Down's syndrome.
    Adlard BP; De Souza SW; Tricklebank MD
    Lancet; 1974 May; 1(7863):936. PubMed ID: 4133464
    [No Abstract]   [Full Text] [Related]  

  • 2. Catabolism of serotonin in Down's syndrome (tisomy 21).
    Kamoun P; Lafourcade G; Jerome H
    Biomedicine; 1974 Oct; 21(10):426-8. PubMed ID: 4281668
    [No Abstract]   [Full Text] [Related]  

  • 3. Diminished activity of platelet monoamine oxidase in Down's syndrome.
    Benson PF; Southgate J
    Am J Hum Genet; 1971 Mar; 23(2):211-4. PubMed ID: 4253914
    [No Abstract]   [Full Text] [Related]  

  • 4. Neurologic aspects of typical and atypical Down's syndrome.
    Paulson GW; Nance W; Son C
    Neurology; 1968 Mar; 18(3):305-6. PubMed ID: 4231810
    [No Abstract]   [Full Text] [Related]  

  • 5. 5-hydroxytryptophan (5-HTP) in Down's syndrome.
    Partington MW; MacDonald MR
    Dev Med Child Neurol; 1971 Jun; 13(3):362-72. PubMed ID: 4255254
    [No Abstract]   [Full Text] [Related]  

  • 6. 5-hydroxyindoleacetic acid in children with Down's syndrome.
    Andersson H; Fällström SP; Lundborg P; Roos BE
    Acta Paediatr Scand; 1973 Mar; 62(2):158-60. PubMed ID: 4266256
    [No Abstract]   [Full Text] [Related]  

  • 7. The metabolism of 5-hydroxytryptamine by blood platelets from children with mongolism.
    Boullin DJ; O'Brien RA
    Biochem Pharmacol; 1973 Jul; 22(13):1647-51. PubMed ID: 4269711
    [No Abstract]   [Full Text] [Related]  

  • 8. Platelet-rich plasma 5-hydroxytryptamine, urinary 5-hydroxyindoleacetic acid and tryptophan ingestion in mongols.
    Airaksinen EM
    J Ment Defic Res; 1971 Dec; 15 Pt 4(0):244-56. PubMed ID: 4279295
    [No Abstract]   [Full Text] [Related]  

  • 9. Letter: Paternal origin of the extra chromosome in Down's syndrome.
    Lancet; 1973 Dec; 2(7840):1257-8. PubMed ID: 4128576
    [No Abstract]   [Full Text] [Related]  

  • 10. 5-hydroxyindole levels in the blood and CSF in Down's syndrome, phenylketonuria and severe mental retardation.
    Tu J; Partington MW
    Dev Med Child Neurol; 1972 Aug; 14(4):457-66. PubMed ID: 4262081
    [No Abstract]   [Full Text] [Related]  

  • 11. Down's syndrome. Central monoamine turnover in patients with diminished platelet serotonin.
    Lott IT; Murphy DL; Chase TN
    Neurology; 1972 Sep; 22(9):967-72. PubMed ID: 4263686
    [No Abstract]   [Full Text] [Related]  

  • 12. Serotonin metabolism in normal and abnormal infants during the perinatal period.
    Tu JB; Wong CY
    Biol Neonate; 1976; 29(3-4):187-93. PubMed ID: 133735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A fluorescence polymorphism associated with Down's syndrome?
    Robinson JA; Newton M
    J Med Genet; 1977 Feb; 14(1):40-5. PubMed ID: 138745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The study of ABO blood groups and Down's syndrome.
    Mayeda K; Luthardt FW; Woolley PV
    Am J Med Technol; 1968 Feb; 34(2):89-97. PubMed ID: 4233945
    [No Abstract]   [Full Text] [Related]  

  • 15. Amino acid profile in Down's syndrome.
    Heggarty HJ; Ball R; Smith M; Henderson MJ
    Arch Dis Child; 1996 Apr; 74(4):347-9. PubMed ID: 8669939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alteration in metabolism of acetylsalicylic acid in children with Down's syndrome: decreased plasma binding and formation of salicyluric acid.
    Ebadi MS; Kugel RB
    Pediatr Res; 1970 Mar; 4(2):187-93. PubMed ID: 4246144
    [No Abstract]   [Full Text] [Related]  

  • 17. Decreased ATPase and increased sodium content of platelets in Down's syndrome. Relation to decreased serotonin content.
    McCoy EE; Segal DJ; Bayer SM; Strynadka KD
    N Engl J Med; 1974 Oct; 291(18):950-3. PubMed ID: 4278048
    [No Abstract]   [Full Text] [Related]  

  • 18. [Satellite chromosome associations in normal humans and in Down's syndrome].
    Zhdanova NS
    Tsitologiia; 1971 Jan; 13(1):42-50. PubMed ID: 4253662
    [No Abstract]   [Full Text] [Related]  

  • 19. Red cell size and uric acid in Down's syndrome.
    Howell A; Mason AS; Brown E; Watts RW; Chanarin I; McPherson K; Ridler MA
    Scand J Haematol; 1973; 11(2):140-7. PubMed ID: 4272676
    [No Abstract]   [Full Text] [Related]  

  • 20. The use of 5-HTP in the treatment of Down's syndrome.
    Weise P; Koch R; Shaw KN; Rosenfeld MJ
    Pediatrics; 1974 Aug; 54(2):165-8. PubMed ID: 4277102
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.